Who
M. Huff Gary
Director
Company insider
Files Form 4 as: Director, Biomerica; CEO, LabCorp Diagnostics, Labcorp Holdings.
In numbers
- Trades disclosed
- 23
- Buys
- 1
- Sells
- 1
- Bought
- $100K
- Sold
- $294K
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 4 Apr 2017
- Last trade
- 20 Aug 2026
- Last filed
- 27 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 20 Aug 2026filed 27 Aug 2026 | BMRA BiomericaDiagnostics & Labs | SEC FORM 4 Bought | $50K31,250 at $1.60 | filing |
| 20 Aug 2026filed 27 Aug 2026 | BMRA BiomericaDiagnostics & Labs | SEC FORM 4 Bought | $50K31,250 at $1.60 | filing |
| 12 Dec 2025filed 31 Dec 2025 | BMRA BiomericaDiagnostics & Labs | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 4 Sep 2018filed 6 Sep 2018 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Code M | —153 | filing |
| 4 Sep 2018filed 6 Sep 2018 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Code F | $12K69 at $169.15 | filing |
| 4 Sep 2018filed 6 Sep 2018 | LH Labcorp Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —153 at $0.00 | filing |
| 30 May 2018filed 1 Jun 2018 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Sold | $294K1,610 at $182.50 | filing |
| 4 Apr 2018filed 6 Apr 2018 | LH Labcorp Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —3,500 at $0.00 | filing |
| 4 Apr 2018filed 6 Apr 2018 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Code M | —3,500 | filing |
| 4 Apr 2018filed 6 Apr 2018 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Code F | $225K1,376 at $163.84 | filing |
| 12 Feb 2018filed 14 Feb 2018 | LH Labcorp Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —6,800 at $0.00 | filing |
| 12 Feb 2018filed 14 Feb 2018 | LH Labcorp Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —1,760 at $0.00 | filing |
| 7 Feb 2018filed 9 Feb 2018 | LH Labcorp Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —446 at $0.00 | filing |
| 7 Feb 2018filed 9 Feb 2018 | LH Labcorp Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —630 at $0.00 | filing |
| 7 Feb 2018filed 9 Feb 2018 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Code M | —446 | filing |
| 7 Feb 2018filed 9 Feb 2018 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Code F | $24K141 at $169.66 | filing |
| 7 Feb 2018filed 9 Feb 2018 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Code M | —630 | filing |
| 7 Feb 2018filed 9 Feb 2018 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Code F | $32K188 at $169.66 | filing |
| 1 Sep 2017filed 23 Oct 2017 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Code M | —153 | filing |
| 1 Sep 2017filed 23 Oct 2017 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Code F | $8,03851 at $157.61 | filing |
News
Contrasting Biomerica (NASDAQ:BMRA) and Envoy Medical (NASDAQ:COCH)BMRA · themarketsdaily.com · 19 Oct 2026Financial Comparison: TerrAscend (OTCMKTS:TSNDF) versus Biomerica (NASDAQ:BMRA)BMRA · dailypolitical.com · 18 Oct 2026Biomerica Reports $1.265 Million in Fiscal First-Quarter Sales and $1.232 Million LossBMRA · econotimes.com · 17 Oct 2026
0 headlines in the last 90 days name M. Huff Gary; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.